earnings
confidence high
sentiment positive
materiality 0.85
Teleflex Q2 adj. EPS $3.73 beats $3.42 YoY; raises FY outlook on BIOTRONIK deal
TELEFLEX INC
2025-Q2 EPS reported
$4.82
revenue$1,481,558,000
- GAAP revenue $780.9M (+4.2% YoY); adjusted constant currency revenue growth +1.0%.
- GAAP diluted EPS $2.77 vs $1.69; adjusted diluted EPS $3.73 vs $3.42.
- Full-year GAAP revenue growth guidance raised to 9.0%-10.0% (from 1.3%-2.3%) due to BIOTRONIK acquisition.
- FY adjusted diluted EPS guidance raised to $13.90-$14.30 from $13.20-$13.60.
- Interventional segment revenue surged 20.4% as reported; OEM and Interventional Urology each declined over 8%.
item 2.02item 7.01item 9.01